深部真菌的耐药性及其耐药机制研究

doi:10.3969/j.issn.1673-8640.2016.09.001

检验医学 ›› 2016, Vol. 31 ›› Issue (9): 735-738.DOI: 10.3969/j.issn.1673-8640.2016.09.001

• 深部真菌的耐药性及耐药机制专题 • 下一篇

深部真菌的耐药性及其耐药机制研究

赵虎

复旦大学附属华东医院检验科, 上海 200040

收稿日期:2016-07-19 出版日期:2016-09-30 发布日期:2016-10-11
作者简介:null
作者简介：赵虎,男,1962年生,博士,教授,主要从事临床微生物学研究。

Drug resistance of invasive fungi and its mechanisms

ZHAO Hu

Department of Clinical Laboratory,Huadong Hospital,Fudan University,Shanghai 200040,China

Received:2016-07-19 Online:2016-09-30 Published:2016-10-11

摘要/Abstract

摘要：

本期“深部真菌的耐药性及耐药机制”专题汇集了4篇论著和1篇综述,阐述了白念珠菌、烟曲霉和新生隐球菌的耐药性及其耐药机制。随着抗真菌药物的大力应用,真菌的耐药性不断上升,研究真菌的耐药机制并探讨新抗真菌药物的作用靶点,可为新抗真菌药物研发和临床抗真菌治疗提供参考依据,这有着重要的临床意义。

关键词: 深部真菌, 白念珠菌, 烟曲霉, 新生隐球菌, 耐药性, 耐药机制

Abstract:

A total of 4 original articles and 1 review about the drug resistance of invasive fungi and its mechanisms are collected for this special topic. The original articles and review describe the drug resistance and mechanisms of Candida albicans,Aspergillus fumigatus and Cryptococcus neoformans. While antifungal agents are widely used in recent years,the drug resistance of fungi increases gradually. It is useful to study the drug resistance mechanism of fungi and the new targets for antifungal agents. It can provide a reference for the research and development of new antifungal agents and the treatment with antifungal agents.

Key words: Invasive fungi, Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, Drug resistance, Drug resistance mechanisms

中图分类号:

R446.1

赵虎. 深部真菌的耐药性及其耐药机制研究[J]. 检验医学, 2016, 31(9): 735-738.

ZHAO Hu. Drug resistance of invasive fungi and its mechanisms[J]. Laboratory Medicine, 2016, 31(9): 735-738.

参考文献 15

1	买佳,王静. 常用抗深部真菌感染药物及真菌对其耐药机制的研究进展[J]. 中国感染与化疗杂志,2015,15(4):395-398.
2	代华,陈木英,陈立宇,等. 深部真菌感染的耐药机制研究进展[J]. 华西医学,2011,26(1):142-145.
3	JENSEN RH,ASTVAD KM,SILVA LV,et al.Stepwise emergence of azole,echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations[J]. J Antimicrob Chemother,2015,70(9):2551-2555.
4	WANG Y,LIU JY,SHI C,et al.Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans[J]. Int J Antimicrob Agents,2015,46(5):552-559.
5	LO HJ,TSENG KY,KAO YY,et al.Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans[J]. Int J Antimicrob Agents,2015,45(6):617-621.
6	TEYMURI M,MAMISHI S,POURAKBARI B,et al.Investigation of ERG11 gene expression among fluconazole-resistant Candida albicans:first report from an Iranian referral paediatric hospital[J]. Br J Biomed Sci,2015,72(1):28-31.
7	MORIO F,PAGNIEZ F,LACROIX C,et al.Amino acid substitutions in the Candida albicans sterol Δ5``2,6-desaturase(Erg3p) confer azole resistance:characterization of two novel mutants with impaired virulence[J]. J Antimicrob Chemother,2012,67(9):2131-2138.
8	NOBILE CJ,NETT JE,ANDES DR,et al.Function of Candida albicans adhesin Hwp1 in biofilm formation[J]. Eukaryot Cell,2006,5(10):1604-1610.
9	FANNING S,XU W,SOLIS N,et al.Divergent targets of Candida albicans biofilm regulator Bcr1 in vitro and in vivo[J]. Eukaryot Cell,2012,11(7):896-904.
10	WALSH TJ,ANAISSIE EJ,DENNING DW,et al.Treatment of aspergillosis:clinical practice guidelines of the Infectious Diseases Society of America[J]. Clin Infect Dis,2008,46(3):327-360.
11	VERMEULEN E,LAGROU K,VERWEIJ PE.Azole resistance in Aspergillus fumigatus:a growing public health concern[J]. Curr Opin Infect Dis,2013,26(6):493-500.
12	VERWEIJ PE,HOWARD SJ,MELCHERS WJ,et al.Azole-resistance in Aspergillus:proposed nomenclature and breakpoints[J]. Drug Resist Updat,2009,12(6):141-147.
13	MITCHELL TG,PERFECT JR.Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans[J]. Clin Microbiol Rev,1995,8(4):515-548.
14	PERFECT JR,DISMUKES WE,DROMER F,et al.Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America[J]. Clin Infect Dis,2010,50(3):291-322.
15	KIRKPATRICK WR,NAJVAR LK,BOCANEGRA R,et al.New guinea pig model of cryptococcal meningitis[J]. Antimicrob Agents Chemother,2007,51(8):3011-3013.

[1]	方咏梅, 章燕, 徐雪莹, 钟峰. 金黄色葡萄球菌耐药性与耐药基因和毒力基因的相关性[J]. 检验医学, 2023, 38(4): 357-361.
[2]	任燕飞, 张敏, 杨涛, 李荣凯, 梁新. 呼吸重症科患者下呼吸道感染病原菌流行病学分析[J]. 检验医学, 2023, 38(2): 157-162.
[3]	邓晨, 戴家泽, 邱丽红, 沈威廷, 蔡木发, 罗文英. 湛江地区高毒力肺炎克雷伯菌分子流行特征[J]. 检验医学, 2023, 38(11): 1026-1031.
[4]	朱丰村, 曾云祥, 金晓立, 曾添, 黄天鹏, 林枝, 周林双. 204株碳青霉烯类耐药肠杆菌目细菌耐药性分析[J]. 检验医学, 2023, 38(1): 60-65.
[5]	李若梅, 周银娣. 2019—2021年某教学医院无菌体液样本分离真菌临床分布及耐药性变迁[J]. 检验医学, 2022, 37(8): 757-760.
[6]	王建英, 王珊珊, 朱俊, 黄晓春, 万玉香, 刘云. 肺癌患者化疗后肺部感染病原菌分布及耐药性分析[J]. 检验医学, 2022, 37(4): 356-359.
[7]	孙英, 李轶, 闫文娟, 荆楠, 马冰. 河南地区少见CRE耐药性分析及碳青霉烯酶初筛实验的临床应用[J]. 检验医学, 2022, 37(2): 146-149.
[8]	张亚茹, 凌丽燕, 陈敏. EUCAST和CLSI微量肉汤稀释法白念珠菌体外药物敏感性试验结果比较[J]. 检验医学, 2022, 37(10): 974-978.
[9]	王立新, 苏云福, 王毅. 临床病原菌磷霉素耐药机制研究进展[J]. 检验医学, 2022, 37(10): 993-997.
[10]	王婧婧, 吴林清, 陈如寿, 王玉丰. 耐万古霉素肠球菌耐药基因、转座子结构和多位点序列分析[J]. 检验医学, 2021, 36(9): 891-895.
[11]	和平安, 陆衍舟, 杨旭, 吕梅, 夏晴, 李庆蓉. 烧伤灶感染病原菌及其耐药性随住院时间变迁的研究进展[J]. 检验医学, 2021, 36(9): 973-975.
[12]	孙刚, 孙辉, 杜彦丹, 李寅雁, 李英智, 董占柱, 佟力军, 彭博. 呼伦贝尔地区MRSA耐药谱及分子流行病学特征分析[J]. 检验医学, 2021, 36(6): 600-603.
[13]	王东江, 郭建. 免疫功能正常者新生隐球菌感染1例报道[J]. 检验医学, 2021, 36(5): 577-580.
[14]	刘先林, 罗丽梅, 谢丽, 谢军. 播散性凹陷诺卡菌合并肺烟曲霉感染1例报道[J]. 检验医学, 2021, 36(12): 1295-1298.
[15]	陈嫣, 崔琳, 黄伟峰, 封正娟, 刘玥, 许学斌. 攀枝花市沙门菌临床分离株血清型和分子分型特征分析[J]. 检验医学, 2021, 36(11): 1125-1130.

深部真菌的耐药性及其耐药机制研究

Drug resistance of invasive fungi and its mechanisms

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 15

相关文章 15

编辑推荐

Metrics